Download Immune system disorder_20150925 - Dept. of Molecular Medicine

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Immune Tolerance
Kyeong Cheon Jung
Department of Pathology
Seoul National University College of Medicine
Immune tolerance

Unresponsiveness to an antigen that is induced
by previous exposure to that antigen
Self tolerance: The normal lack of the ability
to produce an immunological response to
autologous (self) antigens.

Transplantation tolerance: the specific

absence of a destructive immune response to a
transplanted tissue in the absence of
immunosuppression
Abbas: Cellular and Molecular Immunology 7E
Self tolerance

Central tolerance




Negative selection
Receptor editing
Generation of regulatory T
cells
Peripheral tolerance




Clonal anergy
Clonal deletion
Regulatory T cells
T-T interaction
Abbas: Cellular and Molecular Immunology 7E
Thymocyte Development
Nat Immunol. 2006;7:338-334
Central tolerance of T cells
Regulaotry
T cells
Negative selection: mTEC vs DCs
Trends Immunol 2002, 23:364-371
AIRE (Autoimmune Regulator)
A gene or its encoded protein, which functions to
stimulate expression of peripheral tissue protein
antigens in medullary thymic epithelial cells
AIRE & promiscuous gene
expression
Trends Immunol. 2002, 23:364-71
AIRE & central Tolerance

Role of AIRE in self antigen presentation



Role of AIRE+ mTEC



Induction of promiscuous gene expression
Induction of antigen presentation
Clonal deletion
Treg induction
Role of DC

Uptake & presentation of antigen from AIRE+ mTEC 
negative selection
Defect in AIRE gene


autoimmune
polyendocrinopathycandidiasisectodermaldystrophy
(APECED), autoimmune
polyglandular syndrome
type 1 (APS-1)
AIRE knock-out mouse
Defect in central tolerance: Qualitative
difference
B6
SJL
EAE
Brain
Thymus
Nat Med 2000, 6:56-61
Manifestation of APS-1
Peripheral tolerance

Clonal anergy: functional unresponsiveness

Clonal deletion: cell death

Active suppression by regulatory T cells

T-T interaction
T cell anergy in the absence of costimulatory signals
Costimulatory vs. inhibitory
moleccules
Inhibition
(APC : T cell)
Costimulation
(APC : T cell)







B7-2 (CD86) : CD28
B7-1 (CD80) : CD28
CD40 : CD40L (CD154)
ICOSL : ICOS
CD70 : CD27
OX40L (CD134L) : OX40
(CD134)
4-1BBL : 4-1BB



B7-2 : CTLA-4
B7-1 : CTLA-4
PD-L1, PD-L2: PD-1
Circ Res. 2008, 103:1220-1231
CTLA-4/B7 vs. CD28/B7 Interaction
Immunity, 1997, 7: 445-450
Immune dysregulation in human
subjects with heterozygous mutations in CTLA4
Science, 2014, 345: 1623-1627
Development of abatacept &
belatacept
J Allergy Clin Immunol 2008, 121:299
PD-1–PD-L pathway contributes
directly to T cell dysfunction during
chronic viral infection
Nat Immunol 2007, 8:239
PD-L1 KO mice infected with chronic
form of virus
Nature 2006, 439:682-687
PD-1–PD-L pathway in peripheral
tolerance
Am J Transplant. 2012;12:2575-87
PD-1 signaling
Immunol Rev 2010; 236:219-242
Autoimmunity vs. anti-cancer
immunity


Anti-CTLA-4: Ipilimumab
Anti-PD-1: Pembrozumab
http://melanomamissionary.blogspot.com
Adverse Events in Patients Receiving
Anti–PD-L1 Antibody
N Eng J Med 2012, 266:2455-2465
Vitiligo caused by anti-CTLA-4
antibody therapy
http://www.ascopost.com/issues/october-15,-2013/how-to-recognize-and-manage-ipilimumab
-induced-dermatologic-adverse-events.aspx
Activation induced cell death (AICD)
Regulatory T cells: Subsets
nTreg
iTreg
Phenotype
CD25
++
CD103
++
GITR
++
++
CTLA-4
+++
+++
Foxp3
++
++
Cytokine secretion
IL-10
+/++
TGF-
+
Differentiation factors
TGF-, RA
Suppression mechanism
In vitro
Diverse
Diverse
In vivo
Diverse
Diverse
Tr1
Th3
+
+
-/+
+
?
++
-
+++
+
+
+++
IL-10, IFN- TGF-, IL-4
IL-10, TGF-
IL-10, TGF-
TGF-
TGF-
Modidifed from J Leukoc Biol. 2006, 80:458-470 & J Immunol 2003, 171:6323-6327
Differential TCR signalling in negative
selection and Treg cell differentiation
©2012 by Cold Spring Harbor Laboratory Press
Yan Xing, and Kristin A. Hogquist Cold Spring Harb
Perspect Biol 2012;4:a006957
Basic mechanisms used by Treg cells
*IDO, indoleamine 2,3-dioxygenase
Nat Rev Immunol. 2008, 8:523-532
Induction of iTreg by cytokines

TCR stimulation + IL-2 + TGF-  iTreg

Retinoic acid

TGF- + IL-6  Th17

TGF- + RA  Treg

CD103+ DC in gut: retinal dehydrogenase  RA 
Treg (J Exp Med 2007, 204:1757-1764)
Treg deficientyFoxp3 Mutation

Foxp3 mutation


In human: IPEX (Immune dysregulation,
polyendocrinopathy, enteropathy, X-linked
syndrome)
Mouse: Scurfy mutant

IL-2/IL-2R deficiency

TGF deficiency
Immune regulation by T-T
interaction

Idiotype-anti-idiotype network



TCR peptide presentation via MHC I or
II molecules
Immune suppression by anti-idiotype T
cells
Ergotype-anti-ergotype
network


CD25 or HSP60 peptide presentation by
MHC class I or II molecules
Immune suppression by anti-ergotypic T
cells
Induced tolerance
Front Immunol. 2012;3:274
Arrest of DC maturation in semimature
stage via MD-3 Ab treatment
- in vitro surface molecules -
Arrest of DC maturation in semimature
stage via MD-3 Ab treatment
- in vitro cytokine secretion -
Prolongation of porcine islet xenograft
survival in humanize mice via MD-3
treatment
Lack of immune cell infiltration in islet
xenograft of MD-3-treated group
D
H&E
Control
Ab
MD-3
Insulin
CD3
CD68
600
6
P o r c in e C - p e p tid e
5
4
3 .7
6 .4
400
B lo o d g lu c o s e le v e l
3
2
1 .2 3
200
1
100
0 .4
0
0
0
100
200
300
T im e ( d a y )
400
500
600
P o r c in e c - p e p ( n g /m l)
B lo o d g lu c o s e le v e ls (m g /d l)
Long-term survival of islet xenograft in
Rhesus monkeys via combined therapy
Self tolerance

Central tolerance




Negative selection
Receptor editing
Generation of regulatory T cells
Peripheral tolerance




Clonal anergy
Clonal deletion
Regulatory T cells
T-T interaction
Abbas: Cellular and Molecular Immunology 7E
Related documents